Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial-Reference-Cited by-同舟云学术

Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial

Published:2005-11-03 Issue:1 Volume:27 Page:21-28
ISSN:1522-9645
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Wong Cheuk-Kit,Stewart Ralph A.H.,Gao Wanzhen,French John K.,Raffel Christopher,White Harvey D.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/27/1/21/9625063/ehi622.pdf

Reference25 articles.

1. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet1994;343:311–322.

2. Newby KH, Pisano E, Krucoff MW, Green C, Natale A. Incidence and clinical relevance of the occurrence of bundle-branch block in patients treated with thrombolytic therapy. Circulation1996;94:2424–2428.

3. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an Intravenous nPA for Treatment of Infarcting Myocardium Early II trial substudy. Circulation2000;102:2031–2037.

4. Califf RM, Woodlief LH, Harrell FE Jr, Lee KL, White HD, Guerci A, Barbash GI, Simes RJ, Weaver WDD, Simoons ML, Topol EJ for the GUSTO-I Investigators. Selection of thrombolytic therapy for individual patients: development of a clinical model. Am Heart J1997;133:630–639.

5. The Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet2001;358:1855–1863.

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between left bundle branch block and ventricular septal mid-wall fibrosis in patients with preserved left ventricular ejection fraction;Journal of Electrocardiology;2024-03

2. Predictive Effect of Atypical Right Bundle Branch Block on In-Hospital Sudden Cardiac Death and Cardiac Rupture and Long-Term Prognosis in Patients with Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention;2024

3. Association between cardiac conduction block and cardiovascular disease and all-cause mortality: The kailuan study;International Journal of Cardiology;2023-12

4. Transient conduction disturbances acutely after pulsed-field cavotricuspid isthmus ablation: a case report;European Heart Journal - Case Reports;2023-08-01

5. The ratio of QRS/RV6-V1: a new electrocardiographic predictor of short- and long-term adverse clinical outcomes in patients with acute myocardial infarction combined with new-onset right bundle branch block;Frontiers in Cardiovascular Medicine;2023-05-30